Eugene McLaurin
About
In The Last Decade
Eugene McLaurin
33 papers receiving 673 citations
Peers
Comparison fields: 5 of 56
- Public Health, Environmental and Occupational Health 483
- Ophthalmology 345
- Immunology and Allergy 229
- Radiology, Nuclear Medicine and Imaging 149
- Dermatology 119
Countries citing papers authored by Eugene McLaurin
This map shows the geographic impact of Eugene McLaurin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene McLaurin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene McLaurin more than expected).
Fields of papers citing papers by Eugene McLaurin
This network shows the impact of papers produced by Eugene McLaurin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene McLaurin. The network helps show where Eugene McLaurin may publish in the future.
Co-authorship network of co-authors of Eugene McLaurin
This figure shows the co-authorship network connecting the top 25 collaborators of Eugene McLaurin. A scholar is included among the top collaborators of Eugene McLaurin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene McLaurin. Eugene McLaurin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 6 | |
| 4 | 9 | |
| 5 | 12 | |
| 6 | 21 | |
| 7 | 6 | |
| 8 | 13 | |
| 9 | 1 | |
| 10 | Patient-reported Outcomes of Bimatoprost Ocular Ring in an Open-label Extension Study in Patients with Open-angle Glaucoma or Ocular Hypertension | 1 |
| 11 | 20 | |
| 12 | A Single Center Study of the Plasma Pharmacokinetics of DEXTENZATM (dexamethasone insert) 0.4 mg in Healthy Volunteers | 1 |
| 13 | 17 | |
| 14 | 4 | |
| 15 | 181 | |
| 16 | 7 | |
| 17 | 32 | |
| 18 | Phase 3 Study of Efficacy and Safety of Once-daily Olopatadine Hydrochloride, 0.77% Ophthalmic Formulation in Patients With Allergic Conjunctivitis Using the Ora Conjunctival Allergen Challenge Model (Ora-CAC™*) (NCT01743027) | 2 |
| 19 | 170 | |
| 20 | Bepotastine Besilate Ophthalmic Solution 1.5% Reduces Tearing at 8 Hours Following Dosing in a Multi-Site Clinical Trial Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.